SEC Form 4 · accession 0001209191-17-043566
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rory B Riggs
Director
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2017 | A | 1,167 | $0.00 | A | 34,689 | D | |
| Common StockF1 | holding | — | — | — | 226,670 | I | Held by New Ventures I, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.